Skip to content
1 min left
0% read
Infervision logo

Infervision

Technology Company
Philadelphia, Pennsylvania, USA
Founded 2015
71

Infervision is an artificial intelligence high-tech company specialized in medical AI and committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions.

Share:

Infervision Overview

Infervision is an artificial intelligence high-tech company specialized in medical AI and committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions. Infervision effectively uses various types of medical data to create clinically valued products and promotes precision analysis in the medical field, especially in assisted image diagnosis.

Based on years of research preparation, Infervision launched the world's first "Infervision - Artificial Intelligence Precise Healthcare Platform," and is the first to release intelligent X-ray assisted diagnosis products and intelligent CT assisted diagnosis products. Along the years of improvement and development, these products have already been deployed in hundreds of hospitals across the world and achieved seamless integration into physicians' daily workflow to help increase the diagnosis efficiency and accuracy.

The company is also engaged in academic research and has established a deep cooperative relationship with top institutions in Chinese Radiology, combining both medical science and medical technology while laying a solid foundation for artificial intelligence breakthroughs in the medical field. Infervision has established cooperative business partnerships with about 250 top hospitals worldwide across Asia, North America, and Europe, and has successfully broken the barriers between medical data, technology, and application scenarios, creating a unique system of an artificial intelligence computing platform and precise healthcare intelligence system.

Frequently Asked Questions About Infervision

Infervision is a software company. Infervision is an artificial intelligence high-tech company specialized in medical AI and committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions.

Infervision is an artificial intelligence high-tech company specialized in medical AI and committed to applying deep learning technology to assist medical image diagnosis as efficient and accurate solutions. Infervision effectively uses various types of medical data to create clinically valued produ.

Infervision has been operating since 2015. You can verify their legitimacy through their official website and social media presence.

Infervision operates in the software sector of the cryptocurrency industry. Compare Infervision with other software companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Infervision, research their track record (operating since 2015), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Infervision is based in Philadelphia, Pennsylvania, USA, has been operating since 2015. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Infervision is based in Philadelphia, Pennsylvania, USA, North America.

Infervision was founded in 2015. The company currently has 71 employees.

Infervision Details

Infervision Tags

More About Infervision

Work Model Details
Employees work from physical offices.

Latest from Academy

RUNE Wallets Ranked by Security, Speed, and Cross-Chain Features

RUNE Wallets Ranked by Security, Speed, and Cross-Chain Features

RUNE is the native asset of THORChain, the cross-chain liquidity protocol whose vaults were exploited for more than $10 million in May 2026, hitting 12,847 wallets across Bitcoin, Ethereum, BNB Chain, and Base. The breach was a protocol-level failure no wallet could have prevented, but the wallet a holder used decided how fast they saw the pause warning and how exposed their funds were. Native wallets like Asgardex and THORWallet flagged the validator pause at the protocol level, while most multi-chain users only found out once Thorchain was trending online. This comparison grades the leading options for holding and swapping RUNE on security architecture, swap speed, and native cross-chain features. The takeaway is that for RUNE, your real risk exposure depends on wallet choice far more than on any rune price prediction.

8m
WEMIX Swap Mechanics Reveal Why GameFi Traders Pick It

WEMIX Swap Mechanics Reveal Why GameFi Traders Pick It

WEMIX (WEMIX) trades around $0.28, down roughly 98.9% from its 2021 high, but the wemix swap relaunch in January 2026 is a focused bet: a DEX rebuilt for gaming economies, not general-purpose liquidity. WEMIX.fi pairs Uniswap-V3-style concentrated liquidity pools with a liquid staking module on WEMIX 3.0's Stake-based Proof of Authority chain (40 validators, dynamic gas), so sub-$10, latency-sensitive micro-swaps confirm fast and cost a fraction of a cent. The thesis: GameFi traders liquidating loot, buying materials, or cashing out tournament winnings need a chain tuned for tiny high-frequency trades, with game-asset-to-WEMIX-to-stablecoin conversions on one chain and no bridging. The weaknesses are real too: a 40-node validator set, a TVL rank near #69, and thin pair volume. After a $6.2 million February 2025 hack and a second delisting from every major South Korean exchange, the question is whether 35-plus games can drive enough volume to justify a gaming-specific swap layer.

Archie Dutton logoArchie DuttonMay 25, 2026
8m
Gala Whale Wallets Hold More Than Some Central Banks

Gala Whale Wallets Hold More Than Some Central Banks

Gala (GALA) has a problem that no chart pattern or price prediction can capture: three anonymous wallets control roughly forty percent of the token's 47.6 billion circulating supply, a level of concentration that would trip antitrust rules on any regulated equity market. This piece reads the on-chain trail those whales have left - holdings dating back to mid-2022, a Q1 2026 pause in exchange transfers, and a derivatives-led rally in late April - to ask whether they are quietly accumulating or simply waiting to distribute into a thin market. With daily volume near $16.8 million, even a small unwind by these wallets could overwhelm the order book, the same dynamic that made the May 2024 mint exploit so damaging. A new disinflationary burn and a China cross-chain push could offset some of that pressure, but none of it changes the core flaw: the value of GALA, its staking rewards, and every node operator's payout hinge on three private keys.

8m